Stephanie Monlezun - Aelis Farma Chief Officer
| AELIS Stock | 2.20 0.20 8.33% |
Insider
Stephanie Monlezun is Chief Officer of Aelis Farma SA
| Phone | 33 5 57 57 37 70 |
| Web | https://www.aelisfarma.com |
Aelis Farma Management Efficiency
The company has return on total asset (ROA) of (0.1102) % which means that it has lost $0.1102 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.9983) %, meaning that it generated substantial loss on money invested by shareholders. Aelis Farma's management efficiency ratios could be used to measure how well Aelis Farma manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Philippe Depoux | Covivio Hotels | 56 | |
| Christophe Kullmann | Covivio Hotels | 53 | |
| Emmanuel Chabas | Covivio Hotels | 47 | |
| Charles Cessot | Technip Energies BV | 41 | |
| Veronique BeauvaisCrefcoeur | Les Hotels Bav | N/A | |
| Francois Morrisson | Covivio Hotels | 46 | |
| Olivier Esteve | Covivio Hotels | 54 | |
| Jeremy Parola | Reworld Media | 36 | |
| John Mackay | Sartorius Stedim Biotech | 61 | |
| Sebastien Pezet | Covivio Hotels | 36 | |
| Elodie Fonteilles | Reworld Media | N/A | |
| Daniel Frey | Covivio Hotels | N/A | |
| Matthias Stadelmeyer | Reworld Media | 47 | |
| Laetitia Quet | Reworld Media | N/A | |
| Bruno Vibert | Technip Energies BV | 48 | |
| Emeric Servin | Covivio Hotels | 68 | |
| Pierrick Louis | Covivio Hotels | 49 | |
| Wei Cai | Technip Energies BV | N/A | |
| Francoise Debrus | Covivio Hotels | 59 | |
| Joachim Kreuzburg | Sartorius Stedim Biotech | 58 | |
| Hassen Ferroukhi | Reworld Media | N/A | |
Management Performance
| Return On Equity | -1.0 | |||
| Return On Asset | -0.11 |
Aelis Farma SA Management Team
Elected by the shareholders, the Aelis Farma's board of directors comprises two types of representatives: Aelis Farma inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Aelis. The board's role is to monitor Aelis Farma's management team and ensure that shareholders' interests are well served. Aelis Farma's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Aelis Farma's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Pier MD, CEO Director | ||
| Stephanie Monlezun, Chief Officer | ||
| Valrie Scappaticci, Chief Officer |
Aelis Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Aelis Farma a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -1.0 | |||
| Return On Asset | -0.11 | |||
| Profit Margin | (2.04) % | |||
| Operating Margin | (1.01) % | |||
| Current Valuation | 102.61 M | |||
| Shares Outstanding | 12.5 M | |||
| Shares Owned By Institutions | 0.20 % | |||
| Price To Book | 5.85 X | |||
| Price To Sales | 21.46 X | |||
| Revenue | 9.07 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Aelis Stock Analysis
When running Aelis Farma's price analysis, check to measure Aelis Farma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aelis Farma is operating at the current time. Most of Aelis Farma's value examination focuses on studying past and present price action to predict the probability of Aelis Farma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aelis Farma's price. Additionally, you may evaluate how the addition of Aelis Farma to your portfolios can decrease your overall portfolio volatility.